WHO ICTRP trial
The registration of clinical research of Beta-blockers for the treatment of…
ChiCTR-RPC-17014094 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-RPC-17014094 |
|---|---|
| Public title | The registration of clinical research of Beta-blockers for the treatment of coronary heart disease (CHD) patients with curative effect and safety |
| Scientific title | The registration of clinical research of Beta-blockers for the treatment of coronary heart disease (CHD) patients with curative effect and safety |
| Primary sponsor | Sir Run Run Shaw Hospital, School of Medcine, Zhejiang University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Relative factors research |
| Phase | Post-market |
| Countries | China |
| Conditions | Acute Coronary Syndrome |
| Interventions | beta-blockers standard dose group, intolerance to titrate the dose group and all tolerance indications not reach group:Nil |
| Registration date | Dec 22, 2017 |
| Target size | beta-blockers standard dose group, intolerance to titrate the dose group and all… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: